Renovorx to participate in the aegis capital virtual conference on may 3, 2023

Los altos, calif.--(business wire)--renovorx, inc. (“renovorx” or the “company”) (nasdaq: rnxt), a biopharmaceutical company focused on the localized treatment of solid tumors, announced that shaun bagai, ceo of renovorx, will present at the aegis capital virtual conference on may 3rd at 3:30 p.m. et. the online presentation can be accessed here. the conference will be held may 2-4, 2023. mr. bagai will provide a corporate update including recently announced positive interim data for the compan.
RNXT Ratings Summary
RNXT Quant Ranking